{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:37:57Z","timestamp":1761896277264},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.acuro.2015.12.011","type":"journal-article","created":{"date-parts":[[2016,2,13]],"date-time":"2016-02-13T13:27:33Z","timestamp":1455370053000},"page":"303-308","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hidrodistensi\u00f3n bajo anestesia m\u00e1s inyecci\u00f3n de Onabotulinumtoxin A en pacientes con s\u00edndrome de dolor vesical refractario a tratamiento conservador"],"prefix":"10.1016","volume":"40","author":[{"given":"L.","family":"Lorenzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Bonillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Arlandis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Mart\u00ednez-Cuenca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Marzullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Broseta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Boronat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuro.2015.12.011_bib0155","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.acuro.2015.01.006","article-title":"Consenso de la Asociaci\u00f3n Espa\u00f1ola de Urolog\u00eda en el diagn\u00f3stico y manejo del s\u00edndrome de dolor vesical","volume":"39","author":"Esteban","year":"2015","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.acuro.2015.12.011_bib0160","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2007.09.019","article-title":"Diagnostic criteria, classification, and nomenclature for painful bladder syndrome\/interstitial cystitis: An ESSIC proposal","volume":"53","author":"Van de Merwe","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2015.12.011_bib0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/QCO.0b013e32801158df","article-title":"Interstitial cystitis pathogenesis and treatment","volume":"20","author":"Mayer","year":"2007","journal-title":"Curr Opin Infect Dis"},{"issue":"4 Suppl","key":"10.1016\/j.acuro.2015.12.011_bib0170","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.urology.2006.08.1108","article-title":"Neural upregulation in interstitial cystitis","volume":"69","author":"Nazif","year":"2007","journal-title":"Urology"},{"issue":"4 Suppl","key":"10.1016\/j.acuro.2015.12.011_bib0175","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.urology.2006.08.1109","article-title":"The mast cell in interstitial cystitis: Role in pathophysiology and pathogenesis","volume":"69","author":"Sant","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.acuro.2015.12.011_bib0180","unstructured":"Engeler D, Baranowski AP, Borovicka J, Cottrell A, Dinis-Oliveira P, Elneil S, et al.; members of the European Association of Urology (EAU) Guidelines Of\ufb01ce. Guidelines on chronic pelvic pain. In: EAU Guidelines. Edici\u00f3n presentada en el 28th EAU Annual Congress, Milan; 2013. Disponible en: http:\/\/uroweb.org\/guideline\/chronic-pelvic-pain\/"},{"key":"10.1016\/j.acuro.2015.12.011_bib0185","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.urology.2004.06.073","article-title":"Botulinum toxin a has antinociceptive effects in treating interstitial cystitis","volume":"64","author":"Smith","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.acuro.2015.12.011_bib0190","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.eururo.2005.12.002","article-title":"Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: A pilot study","volume":"49","author":"Giannantoni","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2015.12.011_bib0195","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.eururo.2010.02.031","article-title":"Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome\/interstitial cystitis","volume":"58","author":"Pinto","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2015.12.011_bib0200","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00192-010-1162-9","article-title":"Intravesical botulinum toxin A injections in the treatment of painful bladder syndrome\/interstitial cystitis: A systematic review","volume":"21","author":"Tirumuru","year":"2010","journal-title":"Int Urogynecol J"},{"issue":"Suppl 5","key":"10.1016\/j.acuro.2015.12.011_bib0205","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1468-1331.2001.00035.x","article-title":"Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions","volume":"8","author":"Aoki","year":"2001","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.acuro.2015.12.011_bib0210","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1464-410X.2007.07312.x","article-title":"Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation","volume":"101","author":"Lucioni","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2015.12.011_bib0215","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/01.ju.0000143189.19835.f3","article-title":"Inhibitory effect of intravesically applied botulinum toxin A in chronic bladder inflammation","volume":"173","author":"Vemulakonda","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2015.12.011_bib0220","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/bju.12266","article-title":"Onabotulinumtoxin A significantly attenuates bladder afferent nerve firing and inhibits ATP release from the urothelium","volume":"112","author":"Collins","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2015.12.011_bib0225","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.urology.2007.04.038","article-title":"Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis","volume":"70","author":"Liu","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.acuro.2015.12.011_bib0230","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1111\/j.1464-410X.2009.08675.x","article-title":"Urinary nerve growth factor level is increased in patients with interstitial cystitis\/bladder pain syndrome and decreased in responders to treatment","volume":"104","author":"Liu","year":"2009","journal-title":"BJU Int"},{"issue":"1452","key":"10.1016\/j.acuro.2015.12.011_bib0235","first-page":"e1","volume":"82","author":"Peng","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.acuro.2015.12.011_bib0240","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1464-410X.2009.08495.x","article-title":"Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis\/painful bladder syndrome","volume":"104","author":"Kuo","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2015.12.011_bib0245","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00192-013-2267-8","article-title":"A multicentre, prospective, randomised, double-blind study to measure the treatment effectiveness of abobotulinum A (AboBTXA) among women with refractory interstitial cystitis\/bladder pain syndrome","volume":"25","author":"Manning","year":"2014","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.acuro.2015.12.011_bib0305","doi-asserted-by":"crossref","DOI":"10.1002\/nau.22760","article-title":"Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis\/bladder pain syndrome refractory to conventional treatment\u2013A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial","author":"Kuo","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.acuro.2015.12.011_bib0255","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.urology.2008.05.033","article-title":"Validation of treatment benefit scale for assessing subjective outcomes in treatment of overactive bladder","volume":"72","author":"Colman","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.acuro.2015.12.011_bib0260","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jmpt.2003.11.003","article-title":"Assessing the clinical significance of change scores recorded on subjective outcome measures","volume":"27","author":"Hurst","year":"2004","journal-title":"J Manipulative Physiol Ther"},{"key":"10.1016\/j.acuro.2015.12.011_bib0265","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/nau.22530","article-title":"The 3-day bladder diary is a feasible, reliable and valid tool to evaluate the lower urinary tract symptoms in women","volume":"34","author":"Jimenez-Cidre","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.acuro.2015.12.011_bib0270","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0304-3959(83)90126-4","article-title":"The validation of visual analogue scales as ratio scale measures for chronic and experimental pain","volume":"17","author":"Price","year":"1983","journal-title":"Pain"},{"key":"10.1016\/j.acuro.2015.12.011_bib0275","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.eururo.2011.10.004","article-title":"The bladder pain\/interstitial cystitis symptom score: Development, validation, and identification of a cut score","volume":"61","author":"Humphrey","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2015.12.011_bib0280","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.juro.2012.09.027","article-title":"Persistent therapeutic effect of repeated injections of onabotulinum toxin a in refractory bladder pain syndrome\/interstitial cystitis","volume":"189","author":"Pinto","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2015.12.011_bib0285","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.36076\/ppj.2013\/16\/E15","article-title":"Repeated onabotulinumtoxin-a injections provide better results than single injection in treatment of painful bladder syndrome","volume":"16","author":"Kuo","year":"2013","journal-title":"Pain Physician"},{"key":"10.1016\/j.acuro.2015.12.011_bib0290","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1464-410X.2012.11466.x","article-title":"Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis\/bladder pain syndrome","volume":"111","author":"Shie","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2015.12.011_bib0295","first-page":"109","article-title":"Vesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis","volume":"16","author":"Lee","year":"2013","journal-title":"Pain Physician"},{"key":"10.1016\/j.acuro.2015.12.011_bib0300","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.urology.2014.01.018","article-title":"Ulcerative and nonulcerative forms of bladder pain syndrome\/interstitial cystitis do not differ in symptom intensity or response to onabotulinum toxin A","volume":"83","author":"Pinto","year":"2014","journal-title":"Urology"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480616000061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480616000061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T10:12:18Z","timestamp":1718359938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210480616000061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0210480616000061"],"URL":"https:\/\/doi.org\/10.1016\/j.acuro.2015.12.011","relation":{},"ISSN":["0210-4806"],"issn-type":[{"value":"0210-4806","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hidrodistensi\u00f3n bajo anestesia m\u00e1s inyecci\u00f3n de Onabotulinumtoxin A en pacientes con s\u00edndrome de dolor vesical refractario a tratamiento conservador","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2015.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}